{"pageContent": "Introduction: During their lives, 1 in 8 men will be diagnosed with prostate cancer. Several drugs have been shown to decrease prostate cancer risk, but have not been widely used in prostate cancer prevention because of concerns about side-effects and cost-effectiveness. Statins are indicated for prevention of cardiovascular disease, have an excellent benefit to risk profile, and some studies suggest that statins may reduce the risk of prostate cancer.", "metaData": {"source": "Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/15483030/"}}